Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004987962 | SCV005605056 | uncertain significance | Inborn genetic diseases | 2024-10-04 | criteria provided, single submitter | clinical testing | The c.2250G>C (p.Q750H) alteration is located in exon 1 (coding exon 1) of the IRF2BPL gene. This alteration results from a G to C substitution at nucleotide position 2250, causing the glutamine (Q) at amino acid position 750 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |